Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
about
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort studyA randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional surveyEffectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/LevonorgestrelDapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception.Reproductive intentions and family planning practices of pregnant HIV-infected Malawian women on antiretroviral therapy.Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q28081707-6E1B4D98-B194-4596-ACD3-AB8789ADD08EQ33763511-EBB81B59-2BB9-4838-B828-F2897A145A42Q36016655-A63E86D6-730F-4FCB-BCD8-A378D884F7D1Q36566659-11A01C26-A1BF-4495-BB8D-5256D7BF93BDQ38771869-1F30E62E-D512-47B0-A0BB-6F671C0B9B38Q38849112-F7F7E6A2-EFEB-4776-8679-A6A21AA0B6D9Q38850149-7239EE11-5E9D-4AE4-8007-1AF922628A4CQ40791379-029FEF3C-C817-44E2-AC4E-452D8824C515Q42851887-E97B54C8-8743-494F-BBEA-BA6BCEE521CDQ57180790-9525B244-09DB-4384-AB18-E27C4D674938
P2860
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@ast
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@en
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@nl
type
label
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@ast
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@en
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@nl
prefLabel
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@ast
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@en
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@nl
P2093
P356
P1476
Efavirenz- but not nevirapine- ...... b-dermal contraceptive implant
@en
P2093
Concepta Merry
David Back
Kimberly Scarsi
Kristin Darin
Laura Else
Mohammed Lamorde
Pauline Byakika-Kibwika
Shadia Nakalema
Sujan Dilly Penchala
Susan Cohn
P356
10.7448/IAS.17.4.19484
P433
P50
P577
2014-11-02T00:00:00Z